All News Avacta Group Plc

Equities

Delayed London S.E. Other stock markets 11:12:55 2024-06-05 am EDT			5-day change	1st Jan Change
41.06 ^GBX	-3.16%		-1.53%	-64.76%

May. 23	Windward wins deal; Kodal progresses at Bougouni	AN
May. 23	Avacta Group plc Announces Successful Completion of First Cohort and Dosing of Three Patients of the Second Cohort in Arm 2 of Avacta's Ava6000 Phase 1 Trial	CI

Avacta : Targeting the Tumor Microenvironment – June 2024 presentation deck	Jun. 03	PU
Avacta : Annual Report and Accounts 2023	May. 31	PU
Avacta : AGM Notice – 2024	May. 31	PU
Windward wins deal; Kodal progresses at Bougouni	May. 23	AN
Avacta Group plc Announces Successful Completion of First Cohort and Dosing of Three Patients of the Second Cohort in Arm 2 of Avacta's Ava6000 Phase 1 Trial	May. 23	CI
AstraZeneca target raised; Antofagasta lowered	May. 07	AN
Avacta Group plc - Christina Coughlin, MD, PhD, appointed Chief Executive Officer of Avacta Group	May. 01	AQ
Avacta picks Christina Coughlin to replace long-serving CEO	May. 01	AN
EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down	Apr. 30	AN
Avacta Group CEO Steps Down; Successor Appointed	Apr. 30	MT
Transcript : Avacta Group Plc, 2023 Earnings Call, Apr 30, 2024	Apr. 30
Avacta : Results for the Year Ended 31 December 2023	Apr. 30	PU
Avacta : Preliminary Results for the Year Ended 31 December 2023	Apr. 30	PU
Avacta : Christina Coughlin, MD, PhD, appointed Chief Executive Officer of Avacta Group	Apr. 30	PU
Avacta Group Plc Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 30	CI
Avacta Group plc Announces Chief Executive Officer Changes	Apr. 30	CI
Avacta : R&D Spotlight series – Episode 2	Apr. 25	PU
Avacta Group plc - Block Listing Application to AIM	Apr. 24	AQ
Avacta Group plc - Notice of Results	Apr. 24	AQ
First Tin updates Tellerhauser estimates	Apr. 22	AN

No results for this search